AIM
MRNA icon

Aurora Investment Managers’s Moderna MRNA Stock Holding History

Aurora Investment Managers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,515
Closed -$1.5M – 50
2022
Q2 		$1.5M Sell
10,515
-15,279
-59% -$2.18M 1.45% 28
2022
Q1 		$4.44M Buy
+25,794
New +$4.34M 3.31% 8

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aurora Investment Managers's MRNA Position: Q3 2022 in Review

Aurora Investment Managers sold out of Moderna (MRNA) in Q3 2022, closing a stake of 10,515 shares — an estimated $1.5M sold.

Aurora Investment Managers first reported a position in MRNA in Q1 2022 and held it in 2 quarters. The position peaked at $4.44M in Q1 2022. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Aurora Investment Managers reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Aurora Investment Managers sold 10,515 Moderna shares in Q3 2022, an estimated $1.5M.
  • Aurora Investment Managers first reported a position in Moderna in Q1 2022 and held it in 2 quarters.
  • Aurora Investment Managers's Moderna position peaked at $4.44M in Q1 2022.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Aurora Investment Managers's 13F filing for Q3 2022, filed 20 Oct 2022.